Drug,Drug Mechanism,Target Gene(s),Drug Constrained Regulon Activity,Drug Constrained Program Activity,All Regulon(s),Overactive Regulon(s),Underactive Regulon(s),All Program(s),Overactive Program(s),Underactive Program(s),Regulon Activity Summary,Program Activity Summary,Mutations,Regulators,MINER Target Type,max_glioblastoma.multiforme_phase,Other FDA Appr.,TargetMutatedInPatient,MutatedInPatient,TargetType,MutatedDetail,Drug Action,Molecule Type,Target Class,Toxicity Class,MEDDRA Code,CHEMBL_ID,Reactome,GO,Hallmarks
PONEZUMAB,Beta amyloid A4 protein binding agent,APP,1,1,"1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78","1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78",NA,"10,43,47","10,43,47",NA,O: 41 U: 0 A: 41,O: 3 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,BINDING AGENT,Antibody,Membrane receptor,,,CHEMBL1743058,NA:NA:NA:NA:NA,GO_CELLULAR_RESPONSE_TO_NUTRIENT:GO_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS:GO_LIPID_LOCALIZATION:GO_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS:GO_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,HALLMARK_ANGIOGENESIS:HALLMARK_TNFA_SIGNALING_VIA_NFKB
GSK933776,Beta amyloid A4 protein binding agent,APP,1,1,"1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78","1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78",NA,"10,43,47","10,43,47",NA,O: 41 U: 0 A: 41,O: 3 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,BINDING AGENT,Antibody,Membrane receptor,,,CHEMBL2109300,NA:NA:NA:NA:NA,GO_CELLULAR_RESPONSE_TO_NUTRIENT:GO_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS:GO_LIPID_LOCALIZATION:GO_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS:GO_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,HALLMARK_ANGIOGENESIS:HALLMARK_TNFA_SIGNALING_VIA_NFKB
BAPINEUZUMAB,Beta amyloid A4 protein binding agent,APP,1,1,"1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78","1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78",NA,"10,43,47","10,43,47",NA,O: 41 U: 0 A: 41,O: 3 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,BINDING AGENT,Antibody,Membrane receptor,,,CHEMBL2108576,NA:NA:NA:NA:NA,GO_CELLULAR_RESPONSE_TO_NUTRIENT:GO_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS:GO_LIPID_LOCALIZATION:GO_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS:GO_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,HALLMARK_ANGIOGENESIS:HALLMARK_TNFA_SIGNALING_VIA_NFKB
GANTENERUMAB,Beta amyloid A4 protein binding agent,APP,1,1,"1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78","1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78",NA,"10,43,47","10,43,47",NA,O: 41 U: 0 A: 41,O: 3 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,BINDING AGENT,Antibody,Membrane receptor,,,CHEMBL1743025,NA:NA:NA:NA:NA,GO_CELLULAR_RESPONSE_TO_NUTRIENT:GO_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS:GO_LIPID_LOCALIZATION:GO_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS:GO_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,HALLMARK_ANGIOGENESIS:HALLMARK_TNFA_SIGNALING_VIA_NFKB
SOLANEZUMAB,Beta amyloid A4 protein binding agent,APP,1,1,"1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78","1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78",NA,"10,43,47","10,43,47",NA,O: 41 U: 0 A: 41,O: 3 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,BINDING AGENT,Antibody,Membrane receptor,,,CHEMBL1743072,NA:NA:NA:NA:NA,GO_CELLULAR_RESPONSE_TO_NUTRIENT:GO_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS:GO_LIPID_LOCALIZATION:GO_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS:GO_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,HALLMARK_ANGIOGENESIS:HALLMARK_TNFA_SIGNALING_VIA_NFKB
ADUCANUMAB,Beta amyloid A4 protein binding agent,APP,1,1,"1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78","1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78",NA,"10,43,47","10,43,47",NA,O: 41 U: 0 A: 41,O: 3 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,BINDING AGENT,Antibody,Membrane receptor,,,CHEMBL3039540,NA:NA:NA:NA:NA,GO_CELLULAR_RESPONSE_TO_NUTRIENT:GO_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS:GO_LIPID_LOCALIZATION:GO_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS:GO_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,HALLMARK_ANGIOGENESIS:HALLMARK_TNFA_SIGNALING_VIA_NFKB
LECANEMAB,Beta amyloid A4 protein inhibitor,APP,1,1,"1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78","1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78",NA,"10,43,47","10,43,47",NA,O: 41 U: 0 A: 41,O: 3 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Antibody,Membrane receptor,,,CHEMBL3833321,NA:NA:NA:NA:NA,GO_CELLULAR_RESPONSE_TO_NUTRIENT:GO_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS:GO_LIPID_LOCALIZATION:GO_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS:GO_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,HALLMARK_ANGIOGENESIS:HALLMARK_TNFA_SIGNALING_VIA_NFKB
CRENEZUMAB,Beta amyloid A4 protein inhibitor,APP,1,1,"1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78","1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78",NA,"10,43,47","10,43,47",NA,O: 41 U: 0 A: 41,O: 3 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Antibody,Membrane receptor,,,CHEMBL1743004,NA:NA:NA:NA:NA,GO_CELLULAR_RESPONSE_TO_NUTRIENT:GO_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS:GO_LIPID_LOCALIZATION:GO_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS:GO_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,HALLMARK_ANGIOGENESIS:HALLMARK_TNFA_SIGNALING_VIA_NFKB
EFAPROXIRAL,Hemoglobin HbA negative modulator,HBB,1,1,"1981,2339","1981,2339",NA,23,23,NA,O: 2 U: 0 A: 2,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,NEGATIVE MODULATOR,Small molecule,Secreted protein,,,CHEMBL18901,NA:NA:NA:NA:NA,GO_BONE_RESORPTION:GO_HORMONE_CATABOLIC_PROCESS:GO_BONE_REMODELING:GO_GTP_METABOLIC_PROCESS:GO_STEROID_CATABOLIC_PROCESS,
VOXELOTOR,Hemoglobin HbA positive modulator,HBB,1,1,"1981,2339","1981,2339",NA,23,23,NA,O: 2 U: 0 A: 2,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,POSITIVE MODULATOR,Small molecule,Secreted protein,,,CHEMBL4101807,NA:NA:NA:NA:NA,GO_BONE_RESORPTION:GO_HORMONE_CATABOLIC_PROCESS:GO_BONE_REMODELING:GO_GTP_METABOLIC_PROCESS:GO_STEROID_CATABOLIC_PROCESS,
WARFARIN,Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor,VKORC1,1,1,"1184,3090","1184,3090",NA,152,152,NA,O: 2 U: 0 A: 2,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,Vascular toxicity:Carcinogenicity,10047065.0:10029104.0,CHEMBL1464,Cellular response to hypoxia:Regulation of mRNA stability by proteins that bind AU-rich elements:PCP/CE pathway:Regulation of activated PAK-2p34 by proteasome mediated degradation:Vpu mediated degradation of CD4,GO_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_HYPOXIA:GO_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_IN_RESPONSE_TO_STRESS:GO_REGULATION_OF_MRNA_CATABOLIC_PROCESS:GO_PROTEASOMAL_UBIQUITIN_INDEPENDENT_PROTEIN_CATABOLIC_PROCESS:GO_CELLULAR_RESPONSE_TO_OXYGEN_LEVELS,HALLMARK_UNFOLDED_PROTEIN_RESPONSE
DICUMAROL,Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor,VKORC1,1,1,"1184,3090","1184,3090",NA,152,152,NA,O: 2 U: 0 A: 2,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL1466,Cellular response to hypoxia:Regulation of mRNA stability by proteins that bind AU-rich elements:PCP/CE pathway:Regulation of activated PAK-2p34 by proteasome mediated degradation:Vpu mediated degradation of CD4,GO_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_HYPOXIA:GO_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_IN_RESPONSE_TO_STRESS:GO_REGULATION_OF_MRNA_CATABOLIC_PROCESS:GO_PROTEASOMAL_UBIQUITIN_INDEPENDENT_PROTEIN_CATABOLIC_PROCESS:GO_CELLULAR_RESPONSE_TO_OXYGEN_LEVELS,HALLMARK_UNFOLDED_PROTEIN_RESPONSE
PHENINDIONE,Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor,VKORC1,1,1,"1184,3090","1184,3090",NA,152,152,NA,O: 2 U: 0 A: 2,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL711,Cellular response to hypoxia:Regulation of mRNA stability by proteins that bind AU-rich elements:PCP/CE pathway:Regulation of activated PAK-2p34 by proteasome mediated degradation:Vpu mediated degradation of CD4,GO_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_HYPOXIA:GO_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_IN_RESPONSE_TO_STRESS:GO_REGULATION_OF_MRNA_CATABOLIC_PROCESS:GO_PROTEASOMAL_UBIQUITIN_INDEPENDENT_PROTEIN_CATABOLIC_PROCESS:GO_CELLULAR_RESPONSE_TO_OXYGEN_LEVELS,HALLMARK_UNFOLDED_PROTEIN_RESPONSE
ACENOCOUMAROL,Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor,VKORC1,1,1,"1184,3090","1184,3090",NA,152,152,NA,O: 2 U: 0 A: 2,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL397420,Cellular response to hypoxia:Regulation of mRNA stability by proteins that bind AU-rich elements:PCP/CE pathway:Regulation of activated PAK-2p34 by proteasome mediated degradation:Vpu mediated degradation of CD4,GO_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_HYPOXIA:GO_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_IN_RESPONSE_TO_STRESS:GO_REGULATION_OF_MRNA_CATABOLIC_PROCESS:GO_PROTEASOMAL_UBIQUITIN_INDEPENDENT_PROTEIN_CATABOLIC_PROCESS:GO_CELLULAR_RESPONSE_TO_OXYGEN_LEVELS,HALLMARK_UNFOLDED_PROTEIN_RESPONSE
PHENPROCOUMON,Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor,VKORC1,1,1,"1184,3090","1184,3090",NA,152,152,NA,O: 2 U: 0 A: 2,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL1465,Cellular response to hypoxia:Regulation of mRNA stability by proteins that bind AU-rich elements:PCP/CE pathway:Regulation of activated PAK-2p34 by proteasome mediated degradation:Vpu mediated degradation of CD4,GO_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_HYPOXIA:GO_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_IN_RESPONSE_TO_STRESS:GO_REGULATION_OF_MRNA_CATABOLIC_PROCESS:GO_PROTEASOMAL_UBIQUITIN_INDEPENDENT_PROTEIN_CATABOLIC_PROCESS:GO_CELLULAR_RESPONSE_TO_OXYGEN_LEVELS,HALLMARK_UNFOLDED_PROTEIN_RESPONSE
WARFARIN SODIUM,Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor,VKORC1,1,1,"1184,3090","1184,3090",NA,152,152,NA,O: 2 U: 0 A: 2,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,Vascular toxicity:Carcinogenicity,10047065.0:10029104.0,CHEMBL1200879,Cellular response to hypoxia:Regulation of mRNA stability by proteins that bind AU-rich elements:PCP/CE pathway:Regulation of activated PAK-2p34 by proteasome mediated degradation:Vpu mediated degradation of CD4,GO_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_HYPOXIA:GO_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_IN_RESPONSE_TO_STRESS:GO_REGULATION_OF_MRNA_CATABOLIC_PROCESS:GO_PROTEASOMAL_UBIQUITIN_INDEPENDENT_PROTEIN_CATABOLIC_PROCESS:GO_CELLULAR_RESPONSE_TO_OXYGEN_LEVELS,HALLMARK_UNFOLDED_PROTEIN_RESPONSE
WARFARIN POTASSIUM,Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor,VKORC1,1,1,"1184,3090","1184,3090",NA,152,152,NA,O: 2 U: 0 A: 2,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL1200772,Cellular response to hypoxia:Regulation of mRNA stability by proteins that bind AU-rich elements:PCP/CE pathway:Regulation of activated PAK-2p34 by proteasome mediated degradation:Vpu mediated degradation of CD4,GO_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_HYPOXIA:GO_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_IN_RESPONSE_TO_STRESS:GO_REGULATION_OF_MRNA_CATABOLIC_PROCESS:GO_PROTEASOMAL_UBIQUITIN_INDEPENDENT_PROTEIN_CATABOLIC_PROCESS:GO_CELLULAR_RESPONSE_TO_OXYGEN_LEVELS,HALLMARK_UNFOLDED_PROTEIN_RESPONSE
ALEPLASININ,Plasminogen activator inhibitor-1 inhibitor,SERPINE1,1,0.7857142857142857,"100,1015,1218,1239,1260,1526,157,1595,179,1829,1847,1937,209,2090,2197,2213,223,2282,2303,2327,236,2368,2407,2477,2548,2569,2617,2680,2694,2730,2733,2759,2768,2779,2821,2871,302,3021,3070,3128,3136,3199,3253,3272,3460,3640,39,441,465,483,576,599,680,704,768,789","100,1015,1218,1239,1260,1526,157,1595,179,1829,1847,1937,209,2090,2197,2213,223,2282,2303,2327,236,2368,2407,2477,2548,2569,2617,2680,2694,2730,2733,2759,2768,2779,2821,2871,302,3021,3070,3128,3136,3199,3253,3272,3460,3640,39,441,465,483,576,599,680,704,768,789",NA,"1,11,17,31","1,11",NA,O: 56 U: 0 A: 56,O: 2 U: 0 A: 4,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Secreted protein,,,CHEMBL325424,Extracellular matrix organization:ECM proteoglycans:Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs):Laminin interactions:MET activates PTK2 signaling,GO_EXTRACELLULAR_STRUCTURE_ORGANIZATION:GO_CELL_SUBSTRATE_ADHESION:GO_CELL_MATRIX_ADHESION:GO_CELL_CELL_ADHESION_MEDIATED_BY_INTEGRIN:GO_CELL_SUBSTRATE_JUNCTION_ORGANIZATION,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION:HALLMARK_TNFA_SIGNALING_VIA_NFKB:HALLMARK_COMPLEMENT:HALLMARK_APOPTOSIS:HALLMARK_TGF_BETA_SIGNALING:HALLMARK_UV_RESPONSE_DN:HALLMARK_PROTEIN_SECRETION:HALLMARK_INFLAMMATORY_RESPONSE
ENILURACIL,Dihydropyrimidine dehydrogenase inhibitor,DPYD,1,0,"108,2538,268,2686,3329,3712,470,758","108,2538,268,2686,3329,3712,470,758",NA,20,NA,NA,O: 8 U: 0 A: 8,O: 0 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL355200,Interleukin-10 signaling:Regulation of Complement cascade:Complement cascade:Chemokine receptors bind chemokines:NA,GO_HUMORAL_IMMUNE_RESPONSE:GO_NEUTROPHIL_CHEMOTAXIS:GO_NEUTROPHIL_MIGRATION:GO_GRANULOCYTE_CHEMOTAXIS:GO_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN,HALLMARK_COAGULATION
FLUMATINIB,Tyrosine-protein kinase ABL inhibitor,ABL1,1,1,"1011,1034,1092,1152,1180","1011,1034,1092,1152,1180",NA,65,65,NA,O: 5 U: 0 A: 5,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL3545413,Chromatin modifying enzymes:Chromatin organization:RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known:Transcriptional regulation by RUNX1:Transcriptional Regulation by TP53,GO_CHROMATIN_DISASSEMBLY:GO_PROTEIN_DNA_COMPLEX_DISASSEMBLY:GO_COVALENT_CHROMATIN_MODIFICATION:GO_CHROMATIN_REMODELING:GO_PEPTIDYL_LYSINE_MODIFICATION,HALLMARK_MITOTIC_SPINDLE:HALLMARK_G2M_CHECKPOINT
NILOTINIB HYDROCHLORIDE MONOHYDRATE,Tyrosine-protein kinase ABL inhibitor,ABL1,1,1,"1011,1034,1092,1152,1180","1011,1034,1092,1152,1180",NA,65,65,NA,O: 5 U: 0 A: 5,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL1201740,Chromatin modifying enzymes:Chromatin organization:RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known:Transcriptional regulation by RUNX1:Transcriptional Regulation by TP53,GO_CHROMATIN_DISASSEMBLY:GO_PROTEIN_DNA_COMPLEX_DISASSEMBLY:GO_COVALENT_CHROMATIN_MODIFICATION:GO_CHROMATIN_REMODELING:GO_PEPTIDYL_LYSINE_MODIFICATION,HALLMARK_MITOTIC_SPINDLE:HALLMARK_G2M_CHECKPOINT
REBASTINIB,Tyrosine-protein kinase ABL inhibitor,ABL1,1,1,"1011,1034,1092,1152,1180","1011,1034,1092,1152,1180",NA,65,65,NA,O: 5 U: 0 A: 5,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL1738757,Chromatin modifying enzymes:Chromatin organization:RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known:Transcriptional regulation by RUNX1:Transcriptional Regulation by TP53,GO_CHROMATIN_DISASSEMBLY:GO_PROTEIN_DNA_COMPLEX_DISASSEMBLY:GO_COVALENT_CHROMATIN_MODIFICATION:GO_CHROMATIN_REMODELING:GO_PEPTIDYL_LYSINE_MODIFICATION,HALLMARK_MITOTIC_SPINDLE:HALLMARK_G2M_CHECKPOINT
NILOTINIB,Tyrosine-protein kinase ABL inhibitor,ABL1,1,1,"1011,1034,1092,1152,1180","1011,1034,1092,1152,1180",NA,65,65,NA,O: 5 U: 0 A: 5,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,Cardiotoxicity,10007541,CHEMBL255863,Chromatin modifying enzymes:Chromatin organization:RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known:Transcriptional regulation by RUNX1:Transcriptional Regulation by TP53,GO_CHROMATIN_DISASSEMBLY:GO_PROTEIN_DNA_COMPLEX_DISASSEMBLY:GO_COVALENT_CHROMATIN_MODIFICATION:GO_CHROMATIN_REMODELING:GO_PEPTIDYL_LYSINE_MODIFICATION,HALLMARK_MITOTIC_SPINDLE:HALLMARK_G2M_CHECKPOINT
ASCIMINIB,Tyrosine-protein kinase ABL inhibitor,ABL1,1,1,"1011,1034,1092,1152,1180","1011,1034,1092,1152,1180",NA,65,65,NA,O: 5 U: 0 A: 5,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL4208229,Chromatin modifying enzymes:Chromatin organization:RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known:Transcriptional regulation by RUNX1:Transcriptional Regulation by TP53,GO_CHROMATIN_DISASSEMBLY:GO_PROTEIN_DNA_COMPLEX_DISASSEMBLY:GO_COVALENT_CHROMATIN_MODIFICATION:GO_CHROMATIN_REMODELING:GO_PEPTIDYL_LYSINE_MODIFICATION,HALLMARK_MITOTIC_SPINDLE:HALLMARK_G2M_CHECKPOINT
SIMTUZUMAB,Lysyl oxidase homolog 2 inhibitor,LOXL2,1,1,3090,3090,NA,152,152,NA,O: 1 U: 0 A: 1,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Antibody,Enzyme,,,CHEMBL2109667,NA:NA:NA:NA:NA,NA:NA:NA:NA:NA,HALLMARK_UNFOLDED_PROTEIN_RESPONSE
GAVILIMOMAB,Basigin other,BSG,1,1,"1102,934","1102,934",NA,152,152,NA,O: 2 U: 0 A: 2,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,OTHER,Antibody,Membrane receptor,,,CHEMBL2109193,NA:NA:NA:NA:NA,GO_CHAPERONE_MEDIATED_PROTEIN_FOLDING:GO_PROTEIN_INSERTION_INTO_MEMBRANE:GO_REGULATION_OF_PROTEIN_FOLDING:GO_PROTEIN_TARGETING_TO_MITOCHONDRION:GO_PROTEIN_LOCALIZATION_TO_MITOCHONDRION,
ME-344,Mitochondrial complex I (NADH dehydrogenase) inhibitor,NDUFA13,1,1,"865,881,890,902,907","865,881,890,902,907",NA,152,152,NA,O: 5 U: 0 A: 5,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL3545320,"Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.:The citric acid (TCA) cycle and respiratory electron transport:Respiratory electron transport:Complex I biogenesis:Mitochondrial translation initiation",GO_OXIDATIVE_PHOSPHORYLATION:GO_ATP_SYNTHESIS_COUPLED_ELECTRON_TRANSPORT:GO_ATP_METABOLIC_PROCESS:GO_RESPIRATORY_ELECTRON_TRANSPORT_CHAIN:GO_ELECTRON_TRANSPORT_CHAIN,HALLMARK_OXIDATIVE_PHOSPHORYLATION:HALLMARK_DNA_REPAIR:HALLMARK_MYC_TARGETS_V1
FGI-101-1A6,Tumor susceptibility gene 101 protein inhibitor,TSG101,1,1,"881,890","881,890",NA,152,152,NA,O: 2 U: 0 A: 2,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Antibody,Unclassified protein,,,CHEMBL2109593,"Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.:The citric acid (TCA) cycle and respiratory electron transport:Respiratory electron transport:Complex I biogenesis:Mitochondrial translation initiation",GO_OXIDATIVE_PHOSPHORYLATION:GO_ATP_SYNTHESIS_COUPLED_ELECTRON_TRANSPORT:GO_RESPIRATORY_ELECTRON_TRANSPORT_CHAIN:GO_ATP_METABOLIC_PROCESS:GO_ELECTRON_TRANSPORT_CHAIN,HALLMARK_OXIDATIVE_PHOSPHORYLATION:HALLMARK_DNA_REPAIR:HALLMARK_MYC_TARGETS_V1
VATELIZUMAB,Integrin alpha-2 antagonist,ITGA2,1,1,1169,1169,NA,11,11,NA,O: 1 U: 0 A: 1,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,ANTAGONIST,Antibody,Membrane receptor,,,CHEMBL1743086,NA:NA:NA:NA:NA,NA:NA:NA:NA:NA,HALLMARK_COAGULATION:HALLMARK_APICAL_JUNCTION:HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION
BB-10901,Neural cell adhesion molecule 1 binding agent,NCAM1,1,0,1100,1100,NA,133,NA,NA,O: 1 U: 0 A: 1,O: 0 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,BINDING AGENT,Antibody,Adhesion,,,CHEMBL2109484,L1CAM interactions:NCAM signaling for neurite out-growth:NA:NA:NA,GO_CELL_JUNCTION_ASSEMBLY:GO_POSTSYNAPSE_ORGANIZATION:GO_SYNAPSE_ASSEMBLY:GO_DENDRITE_DEVELOPMENT:GO_PROTEIN_POLYMERIZATION,
LORVOTUZUMAB MERTANSINE,Neural cell adhesion molecule 1 binding agent,NCAM1,1,0,1100,1100,NA,133,NA,NA,O: 1 U: 0 A: 1,O: 0 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,BINDING AGENT,Antibody,Adhesion,,,CHEMBL1743037,L1CAM interactions:NCAM signaling for neurite out-growth:NA:NA:NA,GO_CELL_JUNCTION_ASSEMBLY:GO_POSTSYNAPSE_ORGANIZATION:GO_SYNAPSE_ASSEMBLY:GO_DENDRITE_DEVELOPMENT:GO_PROTEIN_POLYMERIZATION,
VARESPLADIB,Phospholipase A2 group IIA inhibitor,PLA2G2A,1,1,"2149,2411","2149,2411",NA,12,12,NA,O: 2 U: 0 A: 2,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL148674,Neutrophil degranulation:Glycogen metabolism:Metabolism of carbohydrates:NA:NA,NA:NA:NA:NA:NA,
GSK2798745,Transient receptor potential cation channel subfamily V member 4 antagonist,TRPV4,1,1,3560,3560,NA,71,71,NA,O: 1 U: 0 A: 1,O: 1 U: 0 A: 1,TRPV4,HSF2,Mutation_Gene,NA,TRUE,FALSE,FALSE,Mutation_Gene,,ANTAGONIST,Small molecule,Ion channel,,,CHEMBL3707225,NA:NA:NA:NA:NA,GO_NEURONAL_STEM_CELL_POPULATION_MAINTENANCE:NA:NA:NA:NA,
ELIGLUSTAT,Ceramide glucosyltransferase inhibitor,UGCG,0.9803921568627451,1,"1144,126,1399,1412,1534,1775,1796,1835,186,1968,1998,2025,2050,2081,2122,2152,2226,2238,2247,2293,2421,2466,2484,2522,2564,2611,2687,2709,2742,2792,2855,2975,3163,3189,3205,3293,3386,3395,3434,3664,3713,3718,449,499,56,584,691,723,760,773,78","1144,126,1399,1412,1534,1775,1796,1835,186,1968,1998,2025,2050,2081,2122,2152,2226,2238,2247,2293,2421,2466,2484,2522,2564,2611,2687,2709,2742,2792,2855,2975,3163,3189,3205,3293,3386,3395,3434,3664,3713,449,499,56,584,691,723,760,773,78",NA,"10,43,47","10,43,47",NA,O: 50 U: 0 A: 51,O: 3 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL2110588,NA:NA:NA:NA:NA,GO_CELLULAR_RESPONSE_TO_NUTRIENT:GO_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS:GO_LIPID_LOCALIZATION:GO_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS:GO_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,HALLMARK_ANGIOGENESIS:HALLMARK_TNFA_SIGNALING_VIA_NFKB
MIGLUSTAT,Ceramide glucosyltransferase inhibitor,UGCG,0.9803921568627451,1,"1144,126,1399,1412,1534,1775,1796,1835,186,1968,1998,2025,2050,2081,2122,2152,2226,2238,2247,2293,2421,2466,2484,2522,2564,2611,2687,2709,2742,2792,2855,2975,3163,3189,3205,3293,3386,3395,3434,3664,3713,3718,449,499,56,584,691,723,760,773,78","1144,126,1399,1412,1534,1775,1796,1835,186,1968,1998,2025,2050,2081,2122,2152,2226,2238,2247,2293,2421,2466,2484,2522,2564,2611,2687,2709,2742,2792,2855,2975,3163,3189,3205,3293,3386,3395,3434,3664,3713,449,499,56,584,691,723,760,773,78",NA,"10,43,47","10,43,47",NA,O: 50 U: 0 A: 51,O: 3 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL1029,NA:NA:NA:NA:NA,GO_CELLULAR_RESPONSE_TO_NUTRIENT:GO_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS:GO_LIPID_LOCALIZATION:GO_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS:GO_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,HALLMARK_ANGIOGENESIS:HALLMARK_TNFA_SIGNALING_VIA_NFKB
ELIGLUSTAT TARTRATE,Ceramide glucosyltransferase inhibitor,UGCG,0.9803921568627451,1,"1144,126,1399,1412,1534,1775,1796,1835,186,1968,1998,2025,2050,2081,2122,2152,2226,2238,2247,2293,2421,2466,2484,2522,2564,2611,2687,2709,2742,2792,2855,2975,3163,3189,3205,3293,3386,3395,3434,3664,3713,3718,449,499,56,584,691,723,760,773,78","1144,126,1399,1412,1534,1775,1796,1835,186,1968,1998,2025,2050,2081,2122,2152,2226,2238,2247,2293,2421,2466,2484,2522,2564,2611,2687,2709,2742,2792,2855,2975,3163,3189,3205,3293,3386,3395,3434,3664,3713,449,499,56,584,691,723,760,773,78",NA,"10,43,47","10,43,47",NA,O: 50 U: 0 A: 51,O: 3 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL4297066,NA:NA:NA:NA:NA,GO_CELLULAR_RESPONSE_TO_NUTRIENT:GO_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS:GO_LIPID_LOCALIZATION:GO_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS:GO_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,HALLMARK_ANGIOGENESIS:HALLMARK_TNFA_SIGNALING_VIA_NFKB
INTERFERON GAMMA-1B,Interferon gamma receptor agonist,IFNGR2,0.9655172413793104,1,"1214,155,1575,1756,203,2032,213,2186,239,2533,2821,283,2848,2873,3019,3201,3252,3267,327,3273,356,380,406,442,460,553,6,603,770","1214,155,1575,1756,203,2032,213,2186,239,2533,2821,283,2873,3019,3201,3252,3267,327,3273,356,380,406,442,460,553,6,603,770",NA,"0,1","0,1",NA,O: 28 U: 0 A: 29,O: 2 U: 0 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,AGONIST,Protein,Membrane receptor,,,CHEMBL1201564,Post-translational protein phosphorylation:Extracellular matrix organization:Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs):ECM proteoglycans:EGR2 and SOX10-mediated initiation of Schwann cell myelination,GO_EXTRACELLULAR_STRUCTURE_ORGANIZATION:GO_CELL_SUBSTRATE_ADHESION:GO_POST_TRANSLATIONAL_PROTEIN_MODIFICATION:NA:NA,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION:HALLMARK_IL6_JAK_STAT3_SIGNALING:HALLMARK_APICAL_JUNCTION:HALLMARK_COMPLEMENT:HALLMARK_PI3K_AKT_MTOR_SIGNALING
MK-8353,MAP kinase ERK1 inhibitor:MAP kinase ERK2 inhibitor,"MAPK1,MAPK3",0.95,0.7,"1164,1194,1507,1531,1633,1672,1694,1776,1903,2018,2047,2218,2417,2705,2803,287,3188,3221,721,756","1164,1194,1507,1531,1633,1672,1694,1776,1903,2018,2047,2218,2417,2705,2803,3188,3221,721,756",NA,"125,126",125,126,O: 19 U: 0 A: 20,O: 1 U: 1 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR:INHIBITOR,Small molecule,Enzyme,,,CHEMBL3545001,Intrinsic Pathway for Apoptosis:Signaling by Insulin receptor:Signaling by high-kinase activity BRAF mutants:MAP2K and MAPK activation:Negative regulation of MAPK pathway,GO_ENDOMEMBRANE_SYSTEM_ORGANIZATION:GO_REGULATION_OF_PH:GO_ORGANELLE_INHERITANCE:GO_MONOVALENT_INORGANIC_CATION_HOMEOSTASIS:GO_REGULATION_OF_CELLULAR_PH,
ULIXERTINIB,MAP kinase ERK2 inhibitor:MAP kinase ERK1 inhibitor,"MAPK1,MAPK3",0.95,0.7,"1164,1194,1507,1531,1633,1672,1694,1776,1903,2018,2047,2218,2417,2705,2803,287,3188,3221,721,756","1164,1194,1507,1531,1633,1672,1694,1776,1903,2018,2047,2218,2417,2705,2803,3188,3221,721,756",NA,"125,126",125,126,O: 19 U: 0 A: 20,O: 1 U: 1 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR:INHIBITOR,Small molecule,Enzyme,,,CHEMBL3545022,Intrinsic Pathway for Apoptosis:Signaling by Insulin receptor:Signaling by high-kinase activity BRAF mutants:MAP2K and MAPK activation:Negative regulation of MAPK pathway,GO_ENDOMEMBRANE_SYSTEM_ORGANIZATION:GO_REGULATION_OF_PH:GO_ORGANELLE_INHERITANCE:GO_MONOVALENT_INORGANIC_CATION_HOMEOSTASIS:GO_REGULATION_OF_CELLULAR_PH,
RAVOXERTINIB,MAP kinase ERK2 inhibitor:MAP kinase ERK1 inhibitor,"MAPK1,MAPK3",0.95,0.7,"1164,1194,1507,1531,1633,1672,1694,1776,1903,2018,2047,2218,2417,2705,2803,287,3188,3221,721,756","1164,1194,1507,1531,1633,1672,1694,1776,1903,2018,2047,2218,2417,2705,2803,3188,3221,721,756",NA,"125,126",125,126,O: 19 U: 0 A: 20,O: 1 U: 1 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR:INHIBITOR,Small molecule,Enzyme,,,CHEMBL3544964,Intrinsic Pathway for Apoptosis:Signaling by Insulin receptor:Signaling by high-kinase activity BRAF mutants:MAP2K and MAPK activation:Negative regulation of MAPK pathway,GO_ENDOMEMBRANE_SYSTEM_ORGANIZATION:GO_REGULATION_OF_PH:GO_ORGANELLE_INHERITANCE:GO_MONOVALENT_INORGANIC_CATION_HOMEOSTASIS:GO_REGULATION_OF_CELLULAR_PH,
CARLUMAB,C-C motif chemokine 2 inhibitor,CCL2,0.9230769230769231,0,"108,1261,2538,268,2686,2854,3635,3712,393,470,66,758,803","108,1261,2538,268,2686,2854,3635,3712,393,470,758,803",NA,20,NA,NA,O: 12 U: 0 A: 13,O: 0 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Antibody,Membrane receptor,,,CHEMBL1742999,Interleukin-10 signaling:Regulation of Complement cascade:Complement cascade:Chemokine receptors bind chemokines:NA,GO_HUMORAL_IMMUNE_RESPONSE:GO_NEUTROPHIL_CHEMOTAXIS:GO_NEUTROPHIL_MIGRATION:GO_GRANULOCYTE_CHEMOTAXIS:GO_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN,HALLMARK_COAGULATION
PEGINTERFERON LAMBDA-1A,Interferon lambda receptor agonist,IL10RB,0.8928571428571429,1,"1483,1556,1575,175,1792,203,2032,213,2848,292,3019,3201,3245,3252,3267,3273,3289,346,38,380,442,460,553,603,705,770,828,99","1483,1556,1575,1792,203,2032,213,292,3019,3201,3245,3252,3267,3273,346,38,380,442,460,553,603,705,770,828,99",NA,0,0,NA,O: 25 U: 0 A: 28,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,AGONIST,Protein,Membrane receptor,,,CHEMBL2108723,Diseases of programmed cell death:Post-translational protein phosphorylation:Neutrophil degranulation:Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs):Platelet degranulation ,NA:NA:NA:NA:NA,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION:HALLMARK_IL6_JAK_STAT3_SIGNALING:HALLMARK_APICAL_JUNCTION:HALLMARK_COMPLEMENT
TOFERSEN,SOD1 mRNA inhibitor,SOD1,0.8333333333333334,1,"1252,1661,1828,2008,3069,552","1661,1828,2008,3069,552",NA,"128,137","128,137",NA,O: 5 U: 0 A: 6,O: 2 U: 0 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Oligonucleotide,Enzyme,,,CHEMBL3833346,NA:NA:NA:NA:NA,GO_CELLULAR_IRON_ION_HOMEOSTASIS:GO_IRON_ION_HOMEOSTASIS:GO_CELLULAR_TRANSITION_METAL_ION_HOMEOSTASIS:GO_TRANSITION_METAL_ION_HOMEOSTASIS:GO_CELLULAR_RESPONSE_TO_NITROGEN_STARVATION,HALLMARK_OXIDATIVE_PHOSPHORYLATION:HALLMARK_ADIPOGENESIS
BIMAGRUMAB,Activin receptor type-2B antagonist,ACVR2B,0.8333333333333334,0.8333333333333334,"1011,1092,1112,1152,1568,987","1011,1092,1112,1152,987",NA,"65,66",65,NA,O: 5 U: 0 A: 6,O: 1 U: 0 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,ANTAGONIST,Antibody,Enzyme,,,CHEMBL3137353,Chromatin modifying enzymes:Chromatin organization:RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known:Transcriptional regulation by RUNX1:Transcriptional Regulation by TP53,GO_COVALENT_CHROMATIN_MODIFICATION:GO_CHROMATIN_DISASSEMBLY:GO_PROTEIN_DNA_COMPLEX_DISASSEMBLY:GO_PEPTIDYL_LYSINE_MODIFICATION:GO_CHROMATIN_REMODELING,HALLMARK_MITOTIC_SPINDLE:HALLMARK_G2M_CHECKPOINT
ONTUXIZUMAB,Endosialin inhibitor,CD248,0.8181818181818182,1,"1346,1830,1990,2039,2194,2661,2909,3530,384,443,713","1346,1830,1990,2039,2194,2661,384,443,713",NA,9,9,NA,O: 9 U: 0 A: 11,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Antibody,Unclassified protein,,,CHEMBL2364659,Extracellular matrix organization:ECM proteoglycans:Collagen biosynthesis and modifying enzymes:Integrin cell surface interactions:Collagen formation,GO_EXTRACELLULAR_STRUCTURE_ORGANIZATION:GO_COLLAGEN_FIBRIL_ORGANIZATION:GO_COLLAGEN_BIOSYNTHETIC_PROCESS:GO_COLLAGEN_METABOLIC_PROCESS:GO_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION:HALLMARK_ANGIOGENESIS:HALLMARK_UV_RESPONSE_DN:HALLMARK_MYOGENESIS
